Symposium 3
Targeting Autoantibodies: A Precision Medicine Approach in Psychotic Disorders

[IS3-3] A novel targeted therapy for anti-NMDA receptor autoantibody-related disorders

*Mitsuyuki Matsumoto¹, Shanni Yamaki¹, Roghiye Kazimi¹, Amir Razai¹, Vallari Eastman¹, Atsuo Kanno¹, Masashi Maeda¹, Satoshi Kubo¹, Mathew Mitchell¹, Carrolee Barlow¹, Jay Lichter¹ (1. Arialys Therapeutics, Inc.)

Keywords:autoantibody, anti-NMDA receptor encephalitis, marmoset model, autoimmune psychosis, precision medicine